trial · primary record
SAR442970
Ulcerative Colitis
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 105 |
| Primary completion | 2029-10-17 |
| Primary endpoint | Proportion of participants who achieve clinical remission at the end of Week 16 by modified Mayo Score (mMS) |
| Registry ID | NCT06975722 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:15.931Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06975722
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.